Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
The British Journal of Diabetes & Vascular Disease
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Kandasamy, N.
Right arrow Articles by Goenka, N.
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Reviews

Review: The role of omega-3 fatty acids in cardiovascular disease, hypertriglyceridaemia and diabetes mellitus

Narayanan Kandasamy

Diabetes Centre, Countess of Chester NHS Foundation Trust, Chester, UK

Franklin Joseph

Diabetes Centre, Countess of Chester NHS Foundation Trust, Chester, UK

Niru Goenka

Diabetes Centre, Countess of Chester NHS Foundation Trust, Chester, UK, Niru.Goenka{at}coch.nhs.uk

It has been suggested that omega-3 fatty acids confer benefit in patients with known coronary heart disease by significantly reducing all-cause mortality and the risk of sudden death caused by cardiac arrhythmias. This may be as a result of the triglyceride-lowering effect of omega-3 fatty acids at high doses. Much of the evidence in favour of omega-3 in cardiovascular disease relates to studies which looked at the effects of increased intake from dietary sources. Oily fish (such as salmon and tuna), flaxseed, canola oil and walnuts, are all rich dietary sources of omega-3 fatty acids. Firm evidence for pharmacological supplementation exists in a few secondary prevention studies and recent National Institute for Health and Clinical Excellence guidance only recommends pharmacological omega-3 supplements to patients within three months of a myocardial infarction, to be continued for up to four years, assuming dietary intake is insufficient. There is currently little evidence for specific benefits of omega-3 supplementation in patients with diabetes.

Key Words: {alpha}-linolenic acid • cardiovascular • diabetes • docosahexaenoic acid • eicosapentaenoic acid • hypertriglyceridaemia • omacor • omega-3.

The British Journal of Diabetes & Vascular Disease, Vol. 8, No. 3, 121-126 (2008)
DOI: 10.1177/14746514080080030301
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?